App-Quantinova.ai

Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus

Dafna Gladman - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Lupus

alpha-galactosidase

Passive Coping: A Predictor of Quality of Life in Rheumatoid Arthritis Patients

Matt Woo - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

A Longitudinal Pilot Study Investigating Changes in Metacarpophalangeal Erosive Damage and Functional Ability in Patients with Rheumatoid Arthritis Using Magnetic Resonance Imaging and Computerized Segmentation

Matthew Jessome - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Comparing Patient Satisfaction with Collaborative-Based and Physician-Based Care in a Rheumatology Clinic

Steven Katz - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Scurvy: A Multifocal Osteomyelitis Mimic

Ali Al-maalawi - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Bone infection

Ascorbic acid

Predictors of Early Minimal Disease Activity in PsA Patients Treated with Anti-TNF in a Real-World Registry

Proton Rahman - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ankylosing spondylitis

Infliximab

Inflammatory Myopathy in the Setting of Cardiomyopathy

Amin Mulji - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Chronic obstructive pulmonary disease

Valproic Acid

Ottawa Panel Evidence-Based Clinical Practice Guidelines for Foot Care in the Management of Juvenile Idiopathic Arthritis

George Wells - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Granulomatosis with Polyangiitis Presenting with Ischemic Intestinal Perforation

Michal Bohdanowicz - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Wegener's granulomatosis

Cyclophosphamide

Patien-s Experience of the Diagnosis and Management of Psoriatic Disease

Daniel Pereira - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Psoriasis

N/A

A Decision Making Needs Assessment of Youth with Juvenile Idiopathic Arthritis and their Caregivers: Preliminary Results from a Narrative Review

Madelyne Laporte-Lafreniere - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Clinical Examination of the Temporomandibular Joint; A EuroTMjoint Initiative

Peter Stoustrup - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

Quality of Cardiovascular Care in RA: Assessing the Current State and Identifying Areas for Improvement

John Esdaile - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

Cardiovascular Risk Prevention in a Canadian Population of Patients with Giant Cell Arteritis

Lillian Barra - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Peripheral artery disease

N/A

Comparison of Health Service Utilization Costs between Aboriginal and Non-Aboriginal Patients with Rheumatoid Arthritis Requiring Biologic Therapy

Yufei Zheng - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Economic Evaluation of Lupus Nephritis in an International Inception Cohort: Comparing the Hospitalization, Medication, Dialysis, and Procedure Costs of those with and without Nephritis

John Hanly - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus nephritis

N/A

The Six-Minute Walk Test as a Patient Performed Measure of Rheumatoid Interstitial Lung Disease

George Tomlinson - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Hyperbaric Oxygen Therapy for the Treatment of Scleroderma Leg Ulcers Case Report and Systematic Review of the Literature

Neha Srivastava - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Imaging Modalities for the Diagnosis and Disease Activity Assessment of Takayasus Arteritis: A Systematic Review and Meta-Analysis

Jacqueline Malette - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

CRUS Control: A Retrospective Analysis of a Canadian Rheumatology Ultrasound Clinic: Preliminary Results

Kam Shojania - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Prednisone

Filters

28841 Abstracts